Increased <scp>Phospho‐AKT</scp> in Blood Cells from <scp> <i>LRRK2</i> G2019S </scp> Mutation Carriers-Reference-Cited by-全球学者库

Increased Phospho‐AKT in Blood Cells from LRRK2 G2019S Mutation Carriers

Published:2022-09-26 Issue:5 Volume:92 Page:888-894
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Annals of Neurology

Author:

Garrido Alicia¹²³^ORCID,Pérez‐Sisqués Leticia⁴⁵,Simonet Cristina¹²³,Campoy‐Campos Genís⁴⁵,Solana‐Balaguer Júlia⁴⁵,Martín‐Flores Núria⁴⁵,Fernández Manel¹²⁵,Soto Marta¹²³,Obiang Donina¹²³,Cámara Ana¹²³,Valldeoriola Francesc¹²³,Muñoz Esteban¹²³,Compta Yaroslau¹²³,Pérez‐Navarro Esther³⁴⁵,Alberch Jordi³⁴⁵,Tolosa Eduardo¹²³^ORCID,Martí María‐José¹²³,Ezquerra Mario¹²³^ORCID,Malagelada Cristina³⁴⁵^ORCID,Fernández‐Santiago Rubén¹²³⁴^ORCID

Affiliation:

1. Parkinson Disease and Movement Disorders Unit, Neurology Service Institut Clínic de Neurociències, Hospital Clínic de Barcelona Barcelona Spain

2. Laboratory of Parkinson Disease and Other Neurodegenerative Movement Disorders Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Institut de Neurociències, Universitat de Barcelona Barcelona Spain

3. Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED: CB06/05/0018‐ISCIII) Barcelona Spain

4. Department of Biomedicine, Faculty of Medicine Universitat de Barcelona Barcelona Spain

5. Institut de Neurociències Universitat de Barcelona Barcelona Spain

Funder

Michael J. Fox Foundation for Parkinson's Research

Ministerio de Economía y Competitividad

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ana.26469

Reference45 articles.

1. G2019S LRRK2 mutation causing Parkinson's disease without Lewy bodies

2. LRRK2 parkinsonism in Tunisia and Norway: A comparative analysis of disease penetrance

3. LRRK2 in Parkinson disease: challenges of clinical trials

4. From The Cover: Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity

5. LRRK2 Phosphorylation, More Than an Epiphenomenon